Discussion  by unknown
Congenital Heart Disease Fadel et al
C
H
D2. Erez E, Kanter KR, TamVK,WilliamsWH. Konno aortoventriculoplasty in chil-
dren and adolescents: from prosthetic valves to the Ross operation. Ann Thorac
Surg. 2002;74:122-6.
3. Turrentine MW, Ruzmetov M, Vijay P, Bills RG, Brown JW. Biological versus
mechanical aortic valve replacement in children. Ann Thorac Surg. 2001;71:
S356-60.
4. Khwaja S, Nigro JJ, Starnes VA. The Ross procedure is an ideal aortic valve re-
placement operation for the teen patient. Semin Thorac Cardiovasc Surg Pediatr
Card Surg Annu. 2005;173-5.
5. Solymar L, S€udow G, Holmgren D. Increase in size of the pulmonary autograft
after the Ross operation in children: growth or dilation? J Thorac Cardiovasc
Surg. 2000;119:4-9.
6. Simon P, Aschauer C, Moidl R, Marx M, Keznickl FP, Eigenbauer E, et al.
Growth of the pulmonary autograft after the Ross operation in childhood. Eur
J Cardiothorac Surg. 2001;19:118-21.
7. Laudito A, Brook MM, Suleman S, Bleiweis MS, Thompson LD, Hanley FL,
et al. The Ross procedure in children and young adults: a word of caution.
J Thorac Cardiovasc Surg. 2001;122:147-53.
8. David TE, Omran A, Ivanov J, Armstrong S, de Sa MP, Sonnenberg B, et al. Di-
lation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc
Surg. 2000;119:210-20.
9. Takkenberg JJ, van Herwerden LA, Galema TW, Bekkers JA, Kleyburg-
Linkers VE, Eijkemans MJ, et al. Serial echocardiographic assessment of neo-
aortic regurgitation and root dimensions after the modified Ross procedure.
J Heart Valve Dis. 2006;15:100-6.
10. Alsoufi B, Manlhiot C, Fadel B, Al-Ahmadi M, Tamim M, McCrindle BW, et al.
The Ross procedure in children: preoperative haemodynamic manifestation has
significant effect on late autograft re-operation. Eur J Cardiothorac Surg.
2010;38:547-55.
11. Reddy VM, McElhinney DB, Phoon CK, Brook MM, Hanley FL. Geometric
mismatch of pulmonary and aortic annuli in children undergoing the Ross proce-
dure: implications for surgical management and autograft valve function.
J Thorac Cardiovasc Surg. 1998;115:1255-62.
12. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA,
et al. Recommendations for evaluation of the severity of native valvular regurgi-
tation with two-dimensional and Doppler echocardiography. J Am Soc Echocar-
diogr. 2003;16:777-802.
13. Alsoufi B, Al-Halees Z, Manlhiot C, McCrindle BW, Al-Ahmadi M,
Sallehuddin A, et al. Mechanical valves versus the Ross procedure for aortic
valve replacement in children: propensity-adjusted comparison of long-term out-
comes. J Thorac Cardiovasc Surg. 2009;137:362-70.
14. Karamlou T, Jang K, Williams WG, Caldarone CA, Van Arsdell G, Coles JG,
et al. Outcomes and associated risk factors for aortic valve replacement in 160
children: a competing-risks analysis. Circulation. 2005;112:3462-9.
15. Alsoufi B, Al-Halees Z, Manlhiot C, McCrindle BW, Kandeel M, Al-Joufan M,
et al. Superior results following the Ross procedure in patients with congenital
heart disease. J Heart Valve Dis. 2010;19:269-77.
16. Mavroudis C, Backer CL, Kaushal S. Aortic stenosis and aortic insufficiency in
children: impact of valvuloplasty and modified Ross-Konno procedure. Semin
Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;76-86.
17. Alsoufi B, Fadel B, Bulbul Z, Al-Ahmadi M, Al-Fayyadh M, Kalloghlian A,
et al. Cardiac reoperations following the Ross procedure in children: spec-
trum of surgery and reoperation results. Eur J Cardiothorac Surg. 2012;
42:25-31.
18. Elkins RC, Knott-Craig CJ, Ward KE, McCue C, Lane MM. Pulmonary au-
tograft in children: realized growth potential. Ann Thorac Surg. 1994;57:
1387-93.
19. Brown JW, Ruzmetov M, Vijay P, Rodefeld MD, Turrentine MW. The Ross-
Konno procedure in children: outcomes, autograft and allograft function, and re-
operations. Ann Thorac Surg. 2006;82:1301-6.
20. Ohye RG, Gomez CA, Ohye BJ, Goldberg CS, Bove EL. The Ross/Konno pro-
cedure in neonates and infants: intermediate-term survival and autograft func-
tion. Ann Thorac Surg. 2001;72:823-30.
21. Hraska V, Krajci M, Haun CH, Ntalakoura K, Razek V, Lacour-Gayet F, et al.
Ross and Ross-Konno procedure in children and adolescents: mid-term results.
Eur J Cardiothorac Surg. 2004;25:742-7.
22. Pasquali SK, Cohen MS, Shera D, Wernovsky G, Spray TL, Marino BS. The re-
lationship between neo-aortic root dilation, insufficiency, and reintervention fol-
lowing the Ross procedure in infants, children, and young adults. J Am Coll
Cardiol. 2007;49:1806-12.436 The Journal of Thoracic and Cardiovascular Surg23. Elkins RC, Lane MM, McCue C. Ross operation in children: late results. J Heart
Valve Dis. 2001;10:736-41.
24. Luciani GB, Favaro A, Casali G, Santini F, Mazzucco A. Ross operation in the
young: a ten-year experience. Ann Thorac Surg. 2005;80:2271-7.Discussion
Dr IvanM.Rebeyka (Edmonton, Alberta, Canada).Your report
of 43 patients who underwent a Ross–Konno procedure at amedian
age of 6 years is especially noteworthy for the 0%need for autograft
reoperation at 8 years follow-up. Despite an increase in the aortic
annular diameter from14 to 21mm, therewas no significant change
in autograft annular root diameter when standardized by Z score.
I have 3 short questions. Because these results seem to be sig-
nificantly better when compared with previous reports with respect
to the need for autograft reoperation, do you think there are spe-
cific details regarding your operative technique or postoperative
management that may account for your superior results or is it sim-
ply because few of your patients had predominant AR as the initial
lesion?
Dr Alsoufi. This subset of patients by definition did not have
pure AR or aortic annulus dilatation. Both dilated aortic annulus
and pure regurgitation are established risk factors for late autograft
failure, so that alone might have contributed to the superior out-
comes in our series. We and other groups have shown that the
Ross procedure for aortic stenosis is associated with improved
freedom from autograft reoperation, so the type of patients does
play a role in the freedom from late autograft failure and
reoperation.
As for the technical aspect, our modified Ross–Konno tech-
nique without using a VSD patch might have contributed to those
superior outcomes. Several groups have shown that cutting into the
annulus and placing a VSD patch might disrupt the annular sup-
port, which might contribute to future neoaortic annulus dilatation,
regurgitation, and failure. The modification of the Ross–Konno
that we have adopted might have contributed to those superior out-
comes by preserving the annular support by not performing a large
incision into the septum and not placing a VSD patch.
One more technical consideration that we have adopted is that
the proximal suture line should be to the actual annulus rather
than to the remnants of the aortic wall, which might protect against
late dilatation.
DrRebeyka.Your article indicated that fresh as opposed to cry-
opreserved homografts were used in approximately two thirds of
the patients. Although fresh homografts are not readily available
in NorthAmerica, I was interested if youwere able to identify a dif-
ference in homograft function and longevity compared with the
cryopreserved homograft that you used in the other third of the pa-
tient group.
Dr Alsoufi. You are talking about the RV-PA homograft of
course?
Dr Rebeyka. Correct.
Dr Alsoufi. The main focus in the current series was not to as-
sess the fate of the pulmonary homograft. However, we have
looked at that in the past in larger series including all children
who have undergone the Ross procedure. In those prior series,
we found that pulmonary homografts were superior to aorticery c February 2013
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Dhomografts, cryopreserved homografts were superior to fresh ho-
mografts, and longer follow-up was associated with more homo-
graft reoperations. One technical modification we have used
might have contributed to improved homograft longevity. We cur-
rently try to trim themuscle rim underneath the pulmonary valve to
a only a few millimeters, which has been shown to decrease the
risk of late homograft failure.
Dr Rebeyka. That is interesting because your article also
seemed to demonstrate a difference in overall conduit reoperation
rate when stratified by surgical era with worse outcomes more re-
cently, and you had a 0% 5-year operation rate in 1995 to 2000 and
a 60% reoperation rate in 2004 to 2007. Do you have any explana-
tion or insight regarding the increased overall reoperation rate in
the more recent era?
Dr Alsoufi. That’s true, and the reason for that discrepancy is
the fact that in the most recent era, we have operated on younger
and smaller patients and subsequently have used smaller homo-
grafts, more fresh and more aortic homografts, which are all risk
factors for homograft failure. Nonetheless, I believe that the larger
prior series that I’ve mentioned are more powered to accurately as-
sess factors affecting homograft survival.
Dr Ross Ungerleider (Winston Salem, NC). You have added so
much to the field over the years, and this is another addition.
Two quick questions for you. I am intrigued, especially for your
patients aged less than 3 years, with the application of your mod-
ified procedure where you do not cut into the interaventricular sep-
tum. I wonder if the Ross–Konno you are describing in this article
(ie, the modified one) is just a subset of your Ross–Konnos, be-
cause there certainly are babies with an enormous size mismatch
between a small aortic annulus and the larger pulmonary valve
where I cannot imagine that you could translocate the pulmonary
valve over to the aortic position without doing some of the typical
ventricular incision. Are these just some of your Ross–Konno pro-
cedures? Do you do some standard Ross–Konno procedures for the
babies with the big mismatch, or are you finding you can do these
even in the babies with a big mismatch?
Dr Alsoufi. This modified technique has been applied to all our
Ross–Konno cases who needed annular enlargement.
Dr Ungerleider. The other question I have relates to the
lack of disruption of the annulus. As I understand, you believeThe Journal of Thoracic and Cathis contributes to the protection of the autograft from dilata-
tion because the Z score values would make you think this is
growth. However, in adult patients who receive Ross proce-
dures there is no disruption of the annulus, and yet it is clear
that they do have autograft dilatation because their Z scores
go up. Just speculate, why would you have protection against
autograft dilatation in infants and not have protection in older
patients, and at what age do you think that lack of protection
occurs?
Dr Alsoufi. It is our hypothesis that the relative preservation of
annular support in the modified Ross–Konnomight offer an advan-
tage over the standard Ross–Konno. However, there are definitely
multiple factors that play a role in late neoaortic annular dilatation.
Even though you preserve the annulus in older patients who do not
require annular enlargement, there is probably a higher subset of
those patients who had pure AR, which is a risk factor for neoaortic
annular dilatation and autograft failure. Likewise, series of older
cohorts include more patients with a discrepancy between the
semilunar valves with the aortic valve annulus larger than the pul-
monary valve, patients with bicuspid aortic valve with regurgita-
tion, and patients with rheumatic fever. All of those risk factors
are more present in the larger population than in the Ross–Konno
population of almost a homogenous group of small patients with
pure stenosis or mixed disease. So other risk factors do interplay
in the risk of aortic annulus and root dilatation.
In addition, when you perform the Ross–Konno operation and
use the pulmonary autograft early in younger patients with signif-
icant LVOTO, most of those patients may have more pulmonary
hypertension than adult patients. So when you transfer that pulmo-
nary autograft to the aortic position at an early age, maybe it is
more primed to adapt to the systemic circulation than if you do
it in an older patient without pulmonary hypertension. Maybe
that affects the autograft remodeling. Another theory is that the
higher blood pressure the autograft is exposed to in older patients
might also contribute at least to a more significant passive early
dilatation.
All of those remain theories, and we cannot have a definitive an-
swer. Nonetheless, your comment underscores that there are sev-
eral factors that affect late dilatation of the neoaortic annulus
and root.rdiovascular Surgery c Volume 145, Number 2 437
